Abstract
Traditional cyclophotocoagulation has typically been reserved for patients with poor vision and end-stage glaucoma, but the use of a safer micropulse technique has allowed the expansion of this treatment option to patients with moderate and/or severe glaucoma. The procedure works by decreasing aqueous production either through ciliary body ablation or through increasing uveoscleral outflow with an 810 nm laser, but does not involve incisions, thus essentially eliminating the risk of bleeding or infection. Micropulse CPC is applicable also to patients with contraindications to incisional glaucoma surgery which may include elderly patients, patients who are at an increased risk of fall, and patients who are unable to make frequent postoperative visits.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Radcliffe, N., Thareja, T. (2017). Micropulse Trans-scleral Cyclophotocoagulation (mTSCPC). In: Rosenberg, E., Nattis, A., Nattis, R. (eds) Operative Dictations in Ophthalmology. Springer, Cham. https://doi.org/10.1007/978-3-319-45495-5_39
Download citation
DOI: https://doi.org/10.1007/978-3-319-45495-5_39
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-45494-8
Online ISBN: 978-3-319-45495-5
eBook Packages: MedicineMedicine (R0)